You have 9 free searches left this month | for more free features.

BB 1101

Showing 26 - 50 of 782

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Laparoscopy, Postoperative Nausea and Vomiting Trial in Jakarta Pusat (Dexamethasone injection, Haloperidol Injection)

Completed
  • Laparoscopy
  • Postoperative Nausea and Vomiting
  • Dexamethasone injection
  • Haloperidol Injection
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Cipto Mangunkusumo Central National Hospital
Feb 15, 2022

Post-endodontic Pain Trial in Cairo (Cryotherapy, Diclofenac sodium, Dexamethasone sodium phosphate)

Recruiting
  • Post-endodontic Pain
  • Cryotherapy
  • +2 more
  • Cairo, Egypt
    Ain Shams University
Oct 13, 2023

Glioblastoma, Malignant Glioma Trial in Duarte (Azeliragon, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Glioblastoma
  • Malignant Glioma
  • Duarte, California
    City of Hope Medical Center
Mar 6, 2023

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Nov 13, 2023

Advanced Malignant Tumor, Cancer Fatigue, Metastatic Malignant Tumor Trial in Houston (drug, behavioral, other)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 3, 2022

Pain, Postoperative, Opioid Use, Recruitment Trial in New York (Bilateral Erector Spinae Plane Block with bupivacaine and

Enrolling by invitation
  • Pain, Postoperative
  • +2 more
  • Bilateral Erector Spinae Plane Block with bupivacaine and dexamethasone
  • No bilateral Erector Spinae Plane Block (no bupivacaine and no dexamethasone)
  • New York, New York
    Hospital for Special Surgery (HSS)
Sep 19, 2022

Blepharoconjunctivitis Trial (1% Azithromycin and 0.1% Dexamethasone, 1% Azithromycin, 0.1% Dexamethasone)

Withdrawn
  • Blepharoconjunctivitis
  • 1% Azithromycin and 0.1% Dexamethasone
  • +2 more
  • (no location specified)
Nov 19, 2021

Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT

Not yet recruiting
  • Multiple Myeloma
  • Dara-VRd intensification, Dara-R maintenance
  • +4 more
  • (no location specified)
Dec 13, 2022

Blepharoconjunctivitis Trial (1% Azithromycin and 0.1% Dexamethasone, 1% Azithromycin, 0.1% Dexamethasone)

Completed
  • Blepharoconjunctivitis
  • 1% Azithromycin and 0.1% Dexamethasone
  • +2 more
  • (no location specified)
Nov 18, 2021

Multiple Myeloma Trial in Worldwide (ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone
  • Atlanta, Georgia
  • +25 more
Aug 31, 2022

Postoperative Nausea and Vomiting, Laparoscopic Cholecystectomy Trial in Tanta (Ondansetron 4mg + dexmedetomidine 0.5 ug/kg +

Recruiting
  • Postoperative Nausea and Vomiting
  • Laparoscopic Cholecystectomy
  • Ondansetron 4mg + dexmedetomidine 0.5 ug/kg + normal saline .
  • Ondansetron 4mg + dexamethasone 8mg + normal saline.
  • Tanta, Algharbia, Egypt
    Tanta University hospitals
Aug 26, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (Carfilzomib, Dexamethasone, Isatuximab)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (drug, other, biological)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 5, 2022

Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2022

Corneal Edema Trial in Giza (Control group, Dexamethasone group, Triamcinolone (TA) group)

Completed
  • Corneal Edema
  • Control group
  • +2 more
  • Giza, Cairo, Egypt
    Khaled G Abueleinen
Feb 27, 2022

Plasma Cell Myeloma Trial in Atlanta (Belantamab Mafodotin, Dexamethasone, Pomalidomide)

Recruiting
  • Plasma Cell Myeloma
  • Belantamab Mafodotin
  • +2 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Jul 21, 2022

Anesthesia, Local Trial in Køge, Slagelse (Dexamethasone 12 mg, Placebo, Dexamethasone 24 mg)

Recruiting
  • Anesthesia, Local
  • Dexamethasone 12 mg
  • +2 more
  • Køge, Zealand Region Of Denmark, Denmark
  • +1 more
Jan 24, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo, East Hills, West Islip (biological, drug, other)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Abatacept
  • +3 more
  • Buffalo, New York
  • +2 more
Dec 22, 2022

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,

Recruiting
  • Acute Bilineal Leukemia
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Glioblastoma Multiforme of Brain Trial in Duarte (CHM-1101 CAR-T cells)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • CHM-1101 CAR-T cells
  • Duarte, California
    City of Hope Medical Center
Dec 19, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer American Joint Committee

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Aug 1, 2022

Postoperative Nausea and Vomiting Trial in Riyadh (Placebo, Ondansetron, Dexamethasone, Midazolam, dexamethasone)

Completed
  • Postoperative Nausea and Vomiting
  • Placebo
  • +2 more
  • Riyadh, Saudi Arabia
    king Khaled Eye Specialist hospital
Oct 10, 2021

Toxoplasmosis, Cerebral Trial in Bandung (Dexamethasone, Placebo)

Recruiting
  • Toxoplasmosis, Cerebral
  • Bandung, Jawa Barat, Indonesia
    Hasan Sadikin General Hospital
Nov 14, 2022

Chronic Postoperative Pain Trial in Xi'an (Dexamethasone Palmitate, Dexamethasone Sodium Phosphate)

Not yet recruiting
  • Chronic Postoperative Pain
  • Dexamethasone Palmitate
  • Dexamethasone Sodium Phosphate
  • Xi'an, China
    Xijing Hospital
Jun 28, 2023